Newsroom | US Fertility statement on the Supreme Court's decision to overturn Roe vs. Wade


US Fertility statement on the Supreme Court's decision to overturn Roe vs. Wade

A letter from Mark Segal, CEO, US Fertility:

Today’s historic and unprecedented Supreme Court decision to overturn Roe vs. Wade is undoubtedly causing consternation and angst among many. As stated in the ASRM response “This decision removes an essential civil liberty that Americans have relied upon for nearly 50 years, one that is well-grounded in the history and best traditions of our country.”

While this decision will undoubtedly have an effect on the entire nation, rest assured US Fertility and its partner practices – Shady Grove Fertility, Reproductive Science Center of the San Francisco Bay Area, Fertility Centers of Illinois, and IVF Florida – will remain vigilant in providing the highest quality care to our patients. We will fight to ensure anyone who comes to a US Fertility practice will continue to have the opportunity to start or grow their family in the most inclusive, respectful, safest way possible.

We stand with the American Society for Reproductive Medicine. We stand with RESOLVE, the National Infertility Awareness Association. We stand for empowering our physicians and care teams. We stand for and believe that health care decisions are best determined between physicians and their patients. We stand for protecting our right to provide the most advanced, evidence-based medicine equitably to all patients. We stand for, beside, and among those struggling with the pain of infertility, those who have experienced a pregnancy loss, or those who face barriers to building their family. We are here for you.

We will remain vigilant and active in protecting access to care. And we will be as transparent as possible in communicating how this may affect our patients’ care as we navigate what tomorrow will bring.

We are #OneUSFertility.

About US Fertility

US Fertility is the largest, physician-led, integrated network of top-tier fertility practices in the United States, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit